Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an ...

Pfizer will offer discounted prices on some of its drugs and avoid U.S. tariffs, in a deal with President Trump.

Some women believe the birth control shot caused their meningiomas, a tumor that grows from the lining of the brain.

Pfizer’s Metsera acquisition boosts its obesity/GLP-1 pipeline and revenue outlook. See why I'm cautiously upgrading my ...

MET-097i’s mid-stage performance “bodes well” for Pfizer’s proposed buyout of Metsera, according to BMO Capital Markets, a ...

M&A headlined for a second straight week as Genmab acquired Merus for $8 billion; Pfizer strikes most-favored-nation deal ...

Metsera, which went public in January this year, could provide Pfizer with strong growth drivers in the obesity treatment ...

Pfizer said it would pay as much as $7.3 billion for Metsera as it looks to profit from soaring demand for weight-loss ...

Metsera released data from mid-stage trials on its lead obesity drug candidate, while a high stakes Medicare open enrollment approaches.

Listen to this Article Your inbox is your home page, and The New Republic makes it smarter. President Donald Trump’s new ...

Vinay Prasad, the agency’s top vaccine official and a key RFK Jr. ally, says the FDA is now unsure if it is safe and ...